Femgevity

What FemGevity actually sells

FemGevity sells concierge menopause and perimenopause care by video, with hormone therapy, lab work and continuing clinician contact built around the visit. The entry point is $129 a month for its hormone balancing plan, and the caveat matters as much as the figure: A single consultation is sold separately at $199 for women who want one expert opinion rather than a subscription. Two trade-offs decide it: the practice does not bill insurance, so the whole cost is out of pocket, and lab panels and medication can land as separate charges on top of the monthly fee.

The longevity and biological age language in its marketing also runs ahead of the published evidence. Judge this practice on the menopause care it delivers, not on the anti-aging framing around it.

The money: what the fee buys and what bills separately

Anyone reading a FemGevity review is usually trying to answer one thing first: what does a full month actually cost? The published subscription rate is the floor, not the ceiling. A concierge model charges for clinician time and continuity, and the things that surround that time, blood panels and prescriptions, are commonly billed by the lab and the pharmacy instead.

What the monthly plan is built to cover

The recurring fee buys access to the practice: consultations, the treatment plan itself, and messaging with the care team between visits. Before you pay, get the boundaries in writing. Ask how many visits a month includes, whether messages get a clinician reply or a coordinator reply, and whether dose changes count as a new visit.

The single-visit route

The $199 consultation is a useful pressure valve. It suits a woman who already has a prescriber and wants a second opinion on a hormone therapy plan, or who wants to test the practice before committing to a monthly charge. Ask one question before booking it: whether any follow-up, refill or lab review afterwards requires you to move onto the subscription.

The charges that can sit on top

• Lab panels and the blood draw, which are often billed by the testing lab rather than the practice.
• Medication, which is dispensed and priced by whichever pharmacy fills the prescription.
• Any repeat testing your clinician recommends during titration.
• Supplements or add-on programs, if the treatment plan includes them.

Twelve months of a subscription plus two lab rounds adds up faster than a monthly figure suggests, so run your own totals before you commit.

Cancellation and refunds

A monthly subscription should be cancellable in the account settings or by a written request. Get the notice period confirmed before your first payment, along with what happens to a lab panel you have paid for but not yet used. Concierge practices frequently bill in advance, so the practical question is whether cancelling mid-cycle ends billing immediately or at the end of the paid month.

Cash pay only: what that does to your budget

This practice does not bill insurance. Nothing is submitted to your plan, no prior authorization is chased, and nothing accrues toward your deductible. The upside is speed and simplicity, since prior authorization is the single slowest step in most hormone therapy pathways. The downside is that your plan may already cover much of this care with an in-network gynecologist for a copay.

Two questions are worth asking the practice directly. First, whether it issues a superbill you can submit yourself for out-of-network reimbursement. Second, whether payments can be made with an HSA or FSA card. Neither should be assumed. If you are on Medicare, note that telehealth benefits apply only through providers who enrol in and bill Medicare, which a cash-pay concierge practice may not do; the rules are set out on Medicare’s telehealth coverage page.

Compare the cash route against what your plan would charge for the same care before you subscribe.

Menopause and perimenopause care: the core pathway

This is a single-condition practice, and that focus is its strongest argument. Menopause care is chronically rushed in general practice, and perimenopause is often mislabelled as stress, thyroid trouble or depression.

Symptoms this pathway targets

The recognised symptom set includes hot flushes and night sweats, disturbed sleep, mood changes, brain fog, joint aches, vaginal dryness, painful sex and urinary symptoms. The National Institute on Aging and MedlinePlus both describe how long this transition can run, which is often years rather than months.

How the diagnosis is usually made

Perimenopause is largely a clinical diagnosis based on your age, cycle pattern and symptoms. Hormone levels swing week to week during the transition, so a single blood test rarely settles the question, as Mayo Clinic explains. A good clinician will take a detailed history before ordering anything.

When you still need in-person care

Video care has hard limits. Bleeding after menopause, heavy or irregular bleeding, a breast lump, pelvic pain or an overdue cervical screening all need an examination and possibly imaging. Ask how the practice refers out when a symptom needs hands-on assessment, and whether it will send notes to your local doctor.

Hormone therapy: what the hormone balancing plan is built around

Systemic hormone therapy remains the most effective treatment for moderate to severe hot flushes and night sweats. Understanding how it is prescribed will tell you far more about a menopause practice than its website copy does.

Estrogen, progesterone and why both usually appear

Estrogen treats the vasomotor symptoms. If you still have a uterus, a progestogen is added to protect the uterine lining from the effect of unopposed estrogen. Delivery routes differ: patches, gels and sprays are absorbed through the skin, while tablets pass through the liver first. MedlinePlus on hormone replacement therapy covers the main formats. Low-dose vaginal estrogen is a separate track used for dryness and painful sex, with far less absorbed into the bloodstream.

Dosing, titration and follow-up

Standard practice is to start at the lowest dose that controls symptoms and adjust from there, which means the follow-up schedule matters more than the first prescription. Ask how soon after starting you are reviewed, who signs off on dose changes, and how often you are seen once you are stable. A concierge fee is only worth paying if it buys that cadence.

Risks, boxed warnings and who should not take it

Labels for systemic estrogen carry boxed warnings covering endometrial cancer, cardiovascular disorders including stroke and blood clots, and probable dementia in older women; combined estrogen plus progestin labelling adds breast cancer risk, as summarised in the FDA-approved estradiol patient information. Much of that framing traces back to the Women’s Health Initiative trial, published in JAMA in 2002, and later analyses show risk varies with age and time since menopause. Hormone therapy is generally not used by women with a history of breast or estrogen-dependent cancer, unexplained vaginal bleeding, active or previous blood clots, recent stroke or heart attack, liver disease, or during pregnancy. A prescriber should walk through your personal and family history before writing anything.

Compounded versus FDA-approved products

Some hormone practices prescribe compounded preparations, including pellets and custom creams. Compounded products are mixed by a pharmacy and are not reviewed or approved by the FDA for safety, effectiveness or manufacturing quality in the way commercial products are. If you are quoted a compounded hormone, ask which pharmacy compounds it, whether an FDA-approved equivalent exists, and why the compounded version was chosen. Our medication guides are a useful place to read up before that conversation.

If hormone therapy is not right for you

Plenty of women cannot or will not take estrogen, and a menopause practice should have a second lane. Fezolinetant, sold as Veozah, was approved by the FDA in 2023 as a non-hormonal treatment for moderate to severe hot flushes, and its labelling requires liver blood tests before and during treatment. Certain antidepressants are also used off-label for vasomotor symptoms, and vaginal moisturisers or local estrogen address dryness on their own.

Confirm with the practice which of these it actually prescribes before you subscribe. A hormone-focused plan is poor value if hormones turn out to be off the table for you.

Lab testing: what the panels can and cannot tell you

Lab work is a visible part of the offer, and it is where a lot of the extra spending hides.

Hormone levels in the transition

FSH and estradiol readings fluctuate sharply during perimenopause, so a single result can mislead. Testing is more useful for ruling other things in or out than for confirming what your symptoms already say.

Thyroid, metabolic and cardiovascular markers

Thyroid dysfunction, anaemia and blood sugar problems mimic menopause symptoms, so a broad baseline panel is clinically reasonable. Cholesterol and glucose readings also matter because cardiovascular risk rises after menopause.

Who bills for the draw

Ask three questions: which lab is used, whether the panel price is inside the monthly fee or invoiced separately, and whether you can take a requisition to a local draw site. Ask the same about repeat testing, since titration often means testing more than once.

Longevity medicine and the biological age pitch

The marketing leans on longevity and feminine longevity language, and this is where a careful reader should slow down. Extended biomarker panels and biological age scores are widely sold, but peer-reviewed evidence that acting on a biological age number improves health outcomes remains thin. Testing is not the same as treatment.

That does not make the panels useless. Standard markers such as lipids, HbA1c, thyroid function and vitamin D genuinely inform care. The distinction worth holding onto is between measurements that change a clinical decision and measurements that mainly produce a dashboard. Ask which specific result would change your treatment plan, and if the answer is vague, decline the upsell.

Quick tip: before paying for an extended panel, ask which single decision the results will change.

Signup and the first visit, step by step

Step 1: Confirm your state is covered

Telemedicine is licensed state by state, so a clinician must hold a licence where you are physically located. Confirm coverage for your state with the practice before you pay anything, especially if you split time between two states.

Step 2: Complete intake and symptom history

Expect questions on cycle history, symptoms, medications, surgical history and personal and family cancer and clot history. Answer this section carefully; it drives what a prescriber can safely offer.

Step 3: The consultation

Care is delivered by video. Ask which clinician type you will see, whether you can request the same clinician for follow-ups, and how long the first visit runs.

Step 4: Labs, if ordered

You either visit a draw site or use an at-home kit, then wait for results before treatment is finalised. Ask how results are shared and whether a clinician talks you through them.

Step 5: Prescription and delivery

Prescriptions go to a pharmacy of the practice’s choosing or, in many cases, one you nominate. Confirm whether you can use a local pharmacy where your insurance drug benefit might still apply to the medication itself, even though the visit is cash pay.

Support, refills and how prescriptions are routed

Concierge pricing implies a level of responsiveness that is worth testing early. Ask which channels reach the care team, portal messaging, phone, or email, and what response time the practice commits to. The practice publishes a phone contact on its public profiles, which is more than many app-only services offer.

Refill mechanics are the second thing to nail down. Ask how many months a prescription is written for, how far in advance you should request a refill, and what happens if you cancel the subscription mid-prescription. There is one more detail worth checking: the practice does not appear in the Surescripts e-prescribing directory we track, so ask directly how prescriptions reach your pharmacy and how a pharmacy queries a script if something looks off.

Escalation matters too. Find out who to contact if you get chest pain, leg swelling, unexpected bleeding or a severe headache while on hormone therapy, and whether that route works outside business hours. A video practice is not an emergency service, and the honest answer to some symptoms is to seek urgent in-person care.

Privacy and your health data

Two different sets of rules usually apply to a telehealth brand. Your medical record with a licensed practice generally sits under HIPAA, described plainly by the US Department of Health and Human Services. The marketing side, symptom quizzes, website analytics, advertising pixels and email lists, often does not.

Read the privacy policy for four specifics before you hand over a detailed hormone and cancer history: what data is collected outside the clinical record, whether any of it is shared with advertising or analytics partners, how lab results are stored and for how long, and how to request deletion of your account data. If a policy reserves broad rights to share de-identified data with partners, decide whether you accept that trade.

Trust and safety: is FemGevity legitimate?

The direct answer is that nothing in the public enforcement record suggests otherwise. No FDA warning letter or enforcement action is on record against the company. It operates as a named telemedicine practice with a public phone line, a company profile in private-market databases and open social channels, which is the opposite of the anonymous script mills that draw regulator attention.

Two gaps are worth stating plainly. The company does not appear in the LegitScript certification record, and that certification is the main third-party check applied to telehealth and pharmacy websites; you can see how the program works on LegitScript’s certification page. Certification is voluntary and many legitimate practices skip it, so its absence is not evidence of wrongdoing, only one fewer external signal. The second gap is state licensure coverage, which is worth confirming for your own state rather than assumed from national marketing.

On the positive side of the ledger, self-pay pricing is published up front, which is not universal in concierge medicine. You can see what an entry-level month costs before you enter an intake funnel. Our scoring methodology explains how pricing transparency, certification status and enforcement records feed the trust score shown alongside this write-up.

Who gets value here, and who should look elsewhere

This practice earns its fee for a specific woman: symptoms that have been dismissed elsewhere, a willingness to pay cash for unhurried clinician time, and a preference for one team that knows her history rather than a rotating cast. If you have already waited months for a gynecology appointment, the speed of a cash-pay route has real value.

Look elsewhere in three cases. If your insurance plan includes a menopause-experienced gynecologist you can actually get in to see, that is usually the cheaper path. If you need in-person examination, imaging or a procedure, a virtual practice can only be part of your care. And if you mainly want a low-cost prescription refill with no coaching or continuity, a concierge subscription is more service than you are buying. Our provider directory tracks other hormone and menopause practices, including ones that bill insurance.

Questions to ask before you pay

The most useful thing a FemGevity review can leave you with is a short script for the sales or intake call. Ask these, and write down the answers:

• What exactly does the monthly fee include, and what is invoiced separately?
• Are lab panels billed by the practice or by the lab, and what is the price range?
• Which clinician will I see, and can I keep the same one?
• How soon is my first follow-up after starting hormone therapy?
• Do you prescribe FDA-approved products, compounded products, or both?
• What is the cancellation notice period, and are prepaid services refundable?
• Are you licensed in my state, and what happens if I move?

If you are switching from another prescriber, ask your current practice for a copy of your records and recent labs, check how many refills remain on your existing prescription, and time your cancellation so you do not run out mid-transition. Put the numbers side by side with our Run My Numbers calculators, and read the editorial coverage on menopause care before committing to a year. If you want a written breakdown of your own options, our free savings report shows the format.

Reputation check

Independent sentiment on this brand is thin, and that is the honest headline. Trustpilot’s profile for femgevityhealth.com has carried a TrustScore of 3.5 out of 5, which is mid-scale rather than strong or weak, and it moves as new reviews arrive; you can read the current profile on Trustpilot. A mid-scale score on a small volume of reviews tells you little about clinical quality either way.

Most of the remaining visible material comes from the company itself: a 2023 press release distributed through financial news wires announcing its concierge telemedicine launch, a private-market company profile, a LinkedIn page and active Instagram marketing of menopause and longevity care. Those confirm a real, funded business that promotes itself energetically. They are not independent evidence of how the care performs. Note also that a similarly named longevity check-up program run by an unrelated European clinic appears in search results, so check the domain before you judge a review you find elsewhere.

Patient reviews collected on this site are moderated, incentivised reviews are always labeled, and sponsored placement never affects scores or rankings. Prices here are desk-verified against the provider’s live site and re-checked monthly, so treat any figure you see elsewhere as a prompt to confirm rather than a quote.

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.